These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 11361852)
1. Gilead announces phase I/II data insufficient for marketing clearance of FORVADE topical gel to treat refractory herpes in patients with AIDS. AIDS Patient Care STDS; 1997 Aug; 11(4):293. PubMed ID: 11361852 [No Abstract] [Full Text] [Related]
2. NDA filed to treat refractory herpes. AIDS Patient Care STDS; 1997 Apr; 11(2):103. PubMed ID: 11361756 [No Abstract] [Full Text] [Related]
3. A new topical treatment for resistant herpes simplex infections. Snoeck R; Andrei G; De Clercq E; Gerard M; Clumeck N; Tricot G; Sadzot-Delvaux C N Engl J Med; 1993 Sep; 329(13):968-9. PubMed ID: 8395657 [No Abstract] [Full Text] [Related]
4. Acyclovir-resistant herpes: expanded access available for cidofovir gel (Forvade). AIDS Treat News; 1997 Feb; (No 264):5. PubMed ID: 11364104 [TBL] [Abstract][Full Text] [Related]
5. Drug-resistant herpes: cidofovir gel in limbo. Interview with Jay Lalezari, M.D. Interview by John S. James. Lalezari J AIDS Treat News; 1997 Nov; (No 283):5-6. PubMed ID: 11364910 [TBL] [Abstract][Full Text] [Related]
6. FDA grants marketing clearance of Vistide for the treatment of CMV retinitis. AIDS Patient Care STDS; 1996 Dec; 10(6):383-4. PubMed ID: 11361576 [No Abstract] [Full Text] [Related]
9. New therapies for cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Cunningham ET West J Med; 1997 Feb; 166(2):138-9. PubMed ID: 9109331 [No Abstract] [Full Text] [Related]
10. SOCA research group stops enrollment. Studies of the Ocular Complications of AIDS. AIDS Patient Care STDS; 1996 Jun; 10(3):188. PubMed ID: 11361634 [No Abstract] [Full Text] [Related]
11. Pharmacia and Upjohn and Gilead sciences receive European recommendation for cidofovir. AIDS Patient Care STDS; 1997 Apr; 11(2):102. PubMed ID: 11361752 [No Abstract] [Full Text] [Related]
12. Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1. Toro JR; Wood LV; Patel NK; Turner ML Arch Dermatol; 2000 Aug; 136(8):983-5. PubMed ID: 10926733 [No Abstract] [Full Text] [Related]
13. Cidofovir use in acyclovir-resistant herpes infection. Martinez CM; Luks-Golger DB Ann Pharmacother; 1997 Dec; 31(12):1519-21. PubMed ID: 9416391 [TBL] [Abstract][Full Text] [Related]
14. AIDS therapy. New hope against blindness. Cohen J Science; 1995 Apr; 268(5209):368-9. PubMed ID: 7716538 [No Abstract] [Full Text] [Related]
15. Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients. Orlando G; Fasolo MM; Beretta R; Signori R; Adriani B; Zanchetta N; Cargnel A AIDS; 1999 Oct; 13(14):1978-80. PubMed ID: 10513659 [No Abstract] [Full Text] [Related]
16. Update on cidofovir for CMV retinitis. MacDougall DS J Int Assoc Physicians AIDS Care; 1997 May; 3(5):18-24. PubMed ID: 11364334 [TBL] [Abstract][Full Text] [Related]
17. Gel for resistant herpes. Vazquez E Posit Aware; 1998; 9(1):16. PubMed ID: 11364993 [TBL] [Abstract][Full Text] [Related]
18. Intravenous cidofovir for recalcitrant verruca vulgaris in the setting of HIV. Hivnor C; Shepard JW; Shapiro MS; Vittorio CC Arch Dermatol; 2004 Jan; 140(1):13-4. PubMed ID: 14732654 [No Abstract] [Full Text] [Related]